United States

ENDO 2021

Time in Range: The Time is Now

Welcome to **ENDO** - the place where leading experts, researchers, and the most respected clinicians in the field come together to share the latest findings in hormone science and discuss breakthroughs in clinical care.

**Endocrine Society** is a global community of physicians and scientists dedicated to accelerating scientific breakthroughs and improving patient health and well being.
<br><br>
For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. **[Read about our history](https://www.endocrine.org/our-community/advancing-endocrinology-and-public-health/history)** and how we continue to serve the endocrine community.

ENDO 2020

ENDO is the place where leading experts, researchers, and the most respected clinicians in the field come together to share the latest findings in hormone science and discuss breakthroughs in clinical care.

technical paper

Patient Perspective Means More Than the Numbers

Starting the Day Right -- Why Sleep Is Critical to Diabetes Care

How Will This Impact FDA Approval of Diabetes Drugs?

Impact of Lipid Polyunsaturation on Dopamine D2 Receptor Activation and Signaling

Chemogenetic Strategies to Explore Roles of Short Chain Fatty Acids in Regulating the Gut-Brain Axis

Using the Available Evidence to Personalize Osteoporosis Treatment

Human Pancreatic Beta Cell Regeneration for Diabetes: A Journey From Impossible to Possible

Dysregulation of Lipid Metabolism: Impact on the Beta Cell in Type 2 Diabetes

Omics to Novel Pathways in the Pancreatic Islet

Ovarian Morphology From Childhood into AdulthoodRelevance to the Diagnosis of Polycystic Ovary Syndrome

https://d3smihljt9218e.cloudfront.net/transcript/25929/subtitle/8ee500e79d0ce48d65b621d041539d66.vtt

English (automatic)

Time in Range: The Time is Now

Downloads

Next from ENDO 2021

Patient Perspective Means More Than the Numbers

Similar lecture

Efficacy and Safety of Higher Dulaglutide Doses (3.0 MG and 4.5 MG) When Added to Metformin in Patients With Type 2 Diabetes: A Phase 3, Randomized, Double-Blind, Parallel ARM Study (Award-11)

Stay up to date with the latest Underline news!

PRESENTATIONS

CONFERENCES

COMPANY

RESOURCES